Clinical Trial Update: Investigating RELEARN Neurofeedback as Treatment for Chronic Musculoskeletal Pain [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial investigating RELEARN Neurofeedback for chronic musculoskeletal pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Knee Pain
• Osteoarthritis
• Pain

Drugs mentioned

• RELEARN Neurofeedback

Snippet

Sponsor: Redo-Neurosystems | Conditions: Chronic Knee Pain, Chronic Pain | Phase 2, Phase 3 | Status: WITHDRAWN